Therapeutic composition comprising a botulinum neurotoxin
a technology of botulinum neurotoxin and composition, which is applied in the direction of drug composition, peptide/protein ingredient, peptide, etc., can solve the problems of no approved product comprising one of the type b-g toxins on the market, antibody-positive patients no longer responding to the complex, and the botulinum toxin complex (irrespective of the complex). achieve the effect of inducing neutralizing antibodies
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Examples
example 1
Isolation of the Pure Neurotoxin
[0023]The pure neurotoxin from Clostridium botulinum type A is obtained by a process based on the process of DasGupta & Sathyamoorthy. Clostridium botulinum type A is cultivated in a 20 I fermenter in a medium consisting of 2% proteose peptone, 1% yeast extract, 1% glucose and 0.05% sodium thioglycolate. After growth for 72 hours, the toxin is precipitated by adding 3 N H2SO4 (final pH=3.5). The precipitated and centrifuged biomass is extracted with 0.2 M sodium phosphate buffer pH 6.0.
[0024]After removal of the nucleic acids by precipitation with protamine sulfate, the toxin is precipitated by adding ammonium sulfate. The precipitate which has been solubilized and dialyzed against 50 mM sodium phosphate pH 6.0 is bound to a DEAE-Sephadex column at the same pH and detached with 150 mM NaCl. This is followed by a chromatography on a QAE-Sephadex column which has been equilibrated with a 50 mM tris / HCl buffer pH 7.9. The toxin is eluted via an NaCl grad...
example 2
Production of a Finished Pharmaceutical Containing Botulinum Neurotoxin
[0025]The purified neurotoxin from Example 1 is used to prepare a solution which comprises 200 mouse LD50 units, 10 mg of sucrose and 2 mg of human serum albumin per ml. The solution (0.5 ml) is dispensed into vials and freeze-dried. The lyophilizates are reconstituted with physiological saline, and the biological activity is determined. The vials comprise 100±30 LD50 units.
example 3
Isolation of Pure Neurotoxin B
[0026]Clostridium botulinum type B is cultivated in the same medium and under the same conditions as type A and is processed as far as the ammonium sulfate precipitation. This is again followed by a DEAE-Sephadex chromatography at pH 6.0. The fractions eluted from the column with 150 mM NaCl are combined and dialyzed against sodium phosphate pH 7.0, followed by a chromatography on QAE-Sephadex. The toxin-containing fractions are chromatographed further on a DEAE-Sephadex column at pH 8.5 (50 mM tris / HCl pH 8.5).
[0027]Finally, the high-purity botulinum toxin type B is obtained by a chromatography on hydroxyapatite equilibrated with 10 mM Na phosphate pH 8.0. The bound homogeneous toxin is eluted with 80 mM Na phosphate pH 8.0 and subsequently the biological activity is determined in the LD50 assay (2-4×107 LD50 units / mg of protein).
PUM
Property | Measurement | Unit |
---|---|---|
pH | aaaaa | aaaaa |
pH | aaaaa | aaaaa |
pH | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com